Therapeutic Solutions International, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Therapeutic Solutions International reported a net loss of $3.26 million for the nine months ended September 30, 2024, driven by increased consulting and legal fees, despite a decrease in research and development expenses.
OTC.Pink
10-Q: Therapeutic Solutions International Reports Mixed Results in Q2 2024 Amidst Ongoing Development
Therapeutic Solutions International reported a net loss for the second quarter of 2024, alongside a decrease in revenue, while continuing to advance its research and development programs.
OTC.Pink
Therapeutic Solutions International reported a net loss of $585,141 for the first quarter of 2024, highlighting ongoing financial challenges and the need for additional capital.